Human Data-driven, Patient-centric and Omics-enabled Target Identification
- 17 November 2022
- Resource Type: Kidney Diseases, Posters, Proteomics, Metabolomics & Biomarkers
Chinook Therapeutics and Evotec joined forces for a patient-centric target identification supported by strong translational evidence to initiate drug discovery programs with a focus on tubular failed repair and cross-talk in the tubulointerstitial niche.